Health Care/Hospital

Oricell OriCAR-017 CAR-T Therapy Clears IND Hurdle, Paving the Way for Global Impact

SHANGHAI, Aug. 10, 2023 /PRNewswire/ -- August 10, 2023, in a groundbreaking development, Oricell Therapeutics Co., Ltd. ("Oricell") has received the green light for its Investigational New Drug (IND) application of OriCAR-017, a cutting-edge CAR-T cell therapy targeting GPRC5D to combat relapsed...

2023-08-10 21:00 2121

Clarity's theranostic prostate cancer trial advances to highest dose level

Highlights * Cohort 2 of the theranostic SECuRE trial investigating 64Cu/67Cu SAR-bisPSMA in metastatic castrate-resistant prostate cancer (mCRPC) has been completed in 3 participants who received therapy with67Cu SAR-bisPSMA at the dose level of 8GBq. * No dose limiting toxicities (DLTs) ha...

2023-08-10 20:58 2232

Waterdrop Presents Advanced Digital Risk Management Solution at 2023 Inslab Insurance Technology Festival

BEIJING, Aug. 10, 2023 /PRNewswire/ -- Waterdrop Inc. ("Waterdrop", the "Company") (NYSE: WDH), a leading technology platform dedicated to insurance and healthcare service with a positive social impact, recently unveiled an innovative, digital intelligence-driven risk management approach at the20...

2023-08-10 19:41 4498

LyondellBasell Awarded the 2023 Global Medical Plastics Company of the Year by Frost & Sullivan

LyondellBasell is among the top three global polyolefin manufacturers in terms of capacity and sustainable solutions, catering to multiple industries, including pharmaceuticals and medical devices. SAN ANTONIO, Aug. 10, 2023 /PRNewswire/ -- Frost & Sullivan recently researched the medical plasti...

2023-08-10 19:00 1696

Baird Medical Submits Disposable Microwave Ablation Needle and MWA System Application to U.S. FDA for Treatment of Soft Tissue Microwave Ablation

GUANGZHOU, China, Aug. 10, 2023 /PRNewswire/ -- Baird Medical Investment Holdings Limited ("Baird Medical" or the "Company"), a leading microwave ablation ("MWA") medical device developer and provider inChina, today announced the 510(k) premarket notification submission of the Company's Disposabl...

2023-08-10 19:00 1740

AffaMed Therapeutics Announces Partner Vistagen Reports Positive Top-Line Results from Phase 3 PALISADE-2 Trial of Fasedienol (PH94B) Nasal Spray in Social Anxiety Disorder

First positive U.S. Phase 3 study of an investigational therapy for social anxiety disorder in over 15 years Statistically significant rapid-onset reduction in patient-reported Subjective Units of Distress Scale (SUDS) score compared to placebo in a public speaking challenge (primary endpoint, p...

2023-08-10 15:49 4129

Pfizer's Pneumococcal 20-Valent Conjugate Vaccine is Now Available in Hong Kong, For Adults Aged 18 Years or Older[1]

* First pneumococcal conjugate vaccine that fights against 20 serotypes leading to most of the invasive pneumococcal diseases and pneumonia[2],[3] — one of the leading causes of death inHong Kong[4] — has been approved by Hong Kong Department of Health inApril 2023 and is now available in Hong ...

2023-08-10 14:15 1632

APRIL Group partners the Indonesian Ministry of Health to elevate primary healthcare levels in Riau province

SINGAPORE, Aug. 10, 2023 /PRNewswire/ -- The Indonesian Ministry of Health (Kemenkes) and Asia Pacific Resources International Limited (APRIL) Group signed a Memorandum of Understanding (MOU) on25 July 2023 at PT. RAPP (Riau Andalan Pulp and Paper) facility - a business unit of APRIL Group. For ...

2023-08-10 12:43 1624

Gates Foundation Selects Nearly 50 Global Health and Development Projects That Will Contribute to Shaping Equitable Access to AI

Global call for locally led innovation will help build an evidence base for use of artificial intelligence (AI) large language models in low- and middle-income countries to improve the livelihood and well-being of communities globally   SEATTLE, Aug. 10, 2023 /PRNewswire/ -- Following an overwhel...

2023-08-10 09:29 2085

Alphamab Oncology will update the research results of several core pipeline products at the 2023 ESMO Annual Meeting

SUZHOU, China, Aug. 10, 2023 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that posters to highlight the company's core pipeline products, PD-L1/CTLA-4 bispecific antibody KN046 and HER2 bispecific antibody KN026, will beannounced at the 2023 European Society for Medical Oncol...

2023-08-10 09:02 2534

Mediballoon's Online Shop is now live, offering a range of medical balloons and tubing for sale. Mediballoon is your best partner for medical device development.

UNION CITY, Calif., Aug. 9, 2023 /PRNewswire/ -- Mediballoon, Inc., a Medeologix company established in 2016 specializing in medical balloon design, development, and scale-up production, is excited to announce the launch of the Mediballoon Online Shop. This newly unveiled platform caters to engin...

2023-08-09 23:00 1334

China Pharma's Candesartan Hypertension Product Passes the Quality and Efficacy Consistency Evaluation of Generic Drugs

HAIKOU, China, Aug. 9, 2023 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), a specialty pharmaceutical company, today announced that its wholly-owned subsidiary Hainan Helpson Medical & Biotechnology Co., Ltd. (hereinafter referred to as ...

2023-08-09 20:30 1740

Zepp Health Corporation to Report Second Quarter 2023 Financial Results on August 21, 2023

Earnings Call Scheduled for 8:30 a.m. ET on August 21, 2023 BEIJING, Aug. 9, 2023 /PRNewswire/ -- Zepp Health Corporation ("Zepp Health" or the "Company") (NYSE: ZEPP), a cloud-based healthcare services provider with world-leading smart wearable technology, today announced that it will report it...

2023-08-09 20:00 4172

Co-creating a New Era for Organoids: Successful Conclusion of the International Society of Organoid Research's First Annual Meeting

SINGAPORE, Aug. 9, 2023 /PRNewswire/ -- From August 7 to 8, 2023, the International Society of Organoid Research (ISoOR) held its inaugural annual meeting inSingapore. Hosted by ISoOR and co-organized by the Pharmacological Society (Singapore) and Scipolis, the conference was themed "Organoid: A...

2023-08-09 16:52 2219

Clarivate Launches Enhanced Search Powered by Generative Artificial Intelligence

Latest iteration of patent pending platform enables life sciences and pharmaceutical companies to access insights from billions of proprietary data points LONDON, Aug. 9, 2023 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they c...

2023-08-09 15:00 1605

CPIC Life (HK) launches branded new increasing whole life insurance product "Ever-growing Whole Life Insurance Plan"

HONG KONG, Aug. 9, 2023 /PRNewswire/ -- China Pacific Life Insurance (H.K.) Company Limited ("CPIC Life (HK)" or "the Company") announced the launch of a new whole life insurance product, "Ever-growing Whole Life Insurance Plan" ("Ever-growing"), providing customers with a resilient financial sol...

2023-08-09 14:54 2364

Pharming announces first patient enrolled in Phase III clinical trial of leniolisib for the treatment of APDS in Japan

Single-arm Phase III study in Japan evaluating leniolisib in patients aged 12 years and older with APDS, a rare primary immunodeficiency LEIDEN, The Netherlands, Aug. 9, 2023 /PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces that...

2023-08-09 13:00 2672

Mindray and Operation Smile Begin 10-Year Partnership to Improve Healthcare for Vulnerable Communities

SHENZHEN, China, Aug. 8, 2023 /PRNewswire/ -- Mindray, a leading global provider of medical devices and solutionsand Operation Smile, a global nonprofit dedicated to transforming the lives of patients and their communities by increasing access to safe surgery and providing high-quality cleft surg...

2023-08-09 11:17 1401

Scratch where it itches - An International-Gold-Medal-Winning Canine Allergen Test Kit by Chula Veterinary Science Lecturer

BANGKOK, Aug. 9, 2023 /PRNewswire/ -- Chula Veterinary Science Lecturers have successfully developed a Serum Test Kit to Identify Canine Atopic Dermatitis(CAD )caused by dust mites.  With a Gold Medal from the Swiss Innovation Contest, the test kit is guaranteed to help identify the allergens with...

2023-08-09 10:00 2262

Everest Medicines to Announce First Half 2023 Financial Results on August 24, 2023

SHANGHAI, Aug. 9, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines and vaccines, today announced that it will report financial results for the fir...

2023-08-09 08:06 1891
1 ... 135136137138139140141 ... 816